These findings shed light on the mechanisms underlying muscle atrophy caused by obesity and T2DM and suggest that NGF could be a potential therapeutic agent for preventing muscle atrophy in these conditions. Here, NGF is linked to obesity due to melanocortin 4 receptor deficiency.